# Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer

> **NCT00201747** · PHASE2 · COMPLETED · sponsor: **Ohio State University Comprehensive Cancer Center** · enrollment: 80 (actual)

## Conditions studied

- Esophageal Cancer
- Esophagus Cancer
- Cancer of Stomach
- Stomach Cancer

## Interventions

- **DRUG:** CPT-11
- **DRUG:** Mitomycin C

## Key facts

- **NCT ID:** NCT00201747
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-09
- **Primary completion:** 2006-10
- **Final completion:** 2010-02
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2017-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00201747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00201747, "Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00201747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*